Open, Prospective, Multicentric, Single-arm, Non-interventional Study to Evaluate the Effectiveness and Safety of Oral Glucobay-M Tablets in Type 2 Diabetes Patient.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Acarbose/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms GLOBE
- Sponsors Bayer
- 10 Jun 2017 Biomarkers information updated
- 05 Mar 2012 Actual patient number is 9664 according to ClinicalTrials.gov.
- 05 Mar 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.